These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33053854)

  • 1. Natural and Synthetic Derivatives of Hydroxycinnamic Acid Modulating the Pathological Transformation of Amyloidogenic Proteins.
    Muronetz VI; Barinova K; Kudryavtseva S; Medvedeva M; Melnikova A; Sevostyanova I; Semenyuk P; Stroylova Y; Sova M
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring cinnamic acid derivatives prevent amyloid transformation of alpha-synuclein.
    Medvedeva M; Barinova K; Melnikova A; Semenyuk P; Kolmogorov V; Gorelkin P; Erofeev A; Muronetz V
    Biochimie; 2020 Mar; 170():128-139. PubMed ID: 31945397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxycinnamic Acid Derivatives from Coffee Extracts Prevent Amyloid Transformation of Alpha-Synuclein.
    Medvedeva M; Kitsilovskaya N; Stroylova Y; Sevostyanova I; Saboury AA; Muronetz V
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
    Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
    Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing Complementary Approaches to Shape the Mechanism of α-Synuclein Oligomerization as a Model of Amyloid Aggregation.
    Giampà M; Amundarain MJ; Herrera MG; Tonali N; Dodero VI
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk Between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson's Disease.
    Werner T; Horvath I; Wittung-Stafshede P
    J Parkinsons Dis; 2020; 10(3):819-830. PubMed ID: 32538869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by Different Types of Chaperones of Amyloid Transformation of Proteins Involved in the Development of Neurodegenerative Diseases.
    Muronetz VI; Kudryavtseva SS; Leisi EV; Kurochkina LP; Barinova KV; Schmalhausen EV
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
    Gautam S; Karmakar S; Batra R; Sharma P; Pradhan P; Singh J; Kundu B; Chowdhury PK
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):589-603. PubMed ID: 28238838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein.
    Ahsan N; Mishra S; Jain MK; Surolia A; Gupta S
    Sci Rep; 2015 May; 5():9862. PubMed ID: 25985292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the Molecular Jam: How Crowding Shapes Protein Aggregation in Neurodegenerative Disorders.
    Patel SP; Nikam T; Sreepathi B; Karankar VS; Jaiswal A; Vardhan SV; Rana A; Toga V; Srivastava N; Saraf SA; Awasthi S
    ACS Chem Biol; 2024 Oct; 19(10):2118-2130. PubMed ID: 39373539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esterification of PQQ Enhances Blood-Brain Barrier Permeability and Inhibitory Activity against Amyloidogenic Protein Fibril Formation.
    Tsukakoshi K; Yoshida W; Kobayashi M; Kobayashi N; Kim J; Kaku T; Iguchi T; Nagasawa K; Asano R; Ikebukuro K; Sode K
    ACS Chem Neurosci; 2018 Dec; 9(12):2898-2903. PubMed ID: 30074759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
    Tavassoly O; Yue J; Vocadlo DJ
    FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seeking a mechanism for the toxicity of oligomeric α-synuclein.
    Roberts HL; Brown DR
    Biomolecules; 2015 Mar; 5(2):282-305. PubMed ID: 25816357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy to reconcile amyloid cross-seeding and amyloid prevention in a binary system of α-synuclein fragmental peptide and hIAPP.
    Tang Y; Zhang D; Liu Y; Zhang Y; Zhou Y; Chang Y; Zheng B; Xu A; Zheng J
    Protein Sci; 2022 Feb; 31(2):485-497. PubMed ID: 34850985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.
    Sorrentino ZA; Vijayaraghavan N; Gorion KM; Riffe CJ; Strang KH; Caldwell J; Giasson BI
    J Biol Chem; 2018 Dec; 293(49):18914-18932. PubMed ID: 30327435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
    Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
    J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycation, Glycolysis, and Neurodegenerative Diseases: Is There Any Connection?
    Muronetz VI; Melnikova AK; Seferbekova ZN; Barinova KV; Schmalhausen EV
    Biochemistry (Mosc); 2017 Aug; 82(8):874-886. PubMed ID: 28941455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.